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Introduction

33
failed to demonstrate significant therapeutic activity, although it should be noted that later 48 studies implicated poor absorption kinetics in these animal models as the primary cause of the 49 lack of efficacy (4). These failures in pre-clinical animal models, coupled with the identification 50 of the highly effective drug isoniazid and later rifampicin, shifted attention away from clinical 51 usage of CFZ to treat TB, although it has been used successfully to treat leprosy since the early 52 1960s. However the desire to shorten the duration of treatment necessary to prevent relapse and 53 the emergence of MDR and XDR TB have renewed interest in both CFZ as well as other related 54 riminophenazine compounds for the treatment of pulmonary tuberculosis (7-9). A recent 55 observational study in Bangladesh examined six combination regimens for efficacy against MDR 56 TB (10). Although all of the regimens contained CFZ during the intensive phase, the two 57 regimens with the highest rate of cure also contained CFZ during the continuation phase.
58
Similarly encouraging results were observed in BALB/c mice (11), demonstrating that the 59 addition of CFZ to a 9-month second-line regimen significantly increased the rate of killing and 
85
Igor Kramnik's group discovered that the C3HeB/FeJ mouse strain (commonly referred 86 to as the Kramnik mouse model) was highly susceptible to infection with M. tuberculosis (21).
87
They also determined that this increased susceptibility was mediated to a large degree by 
95
These granulomas bear a striking resemblance to human pulmonary lesions, and may facilitate 96 more realistic modeling of microenvironmental conditions not found within conventional mouse 97 models.
98
Due to renewed interest in use of CFZ as an adjunct to novel chemotherapeutic regimens, 
Materials and Methods
105
Animals
106
Female specific pathogen-free C3HeB/FeJ and BALB/c mice aged 6-8 weeks were 107 purchased from Jackson Laboratories, Bar Harbor ME. Mice were housed in a bio-safety level III
108
animal facility and maintained with sterile bedding, water, and mouse chow. Specific pathogen-109 free status was verified by testing sentinel mice housed within the colony for 13 known mouse 110 pathogens.
111
Bacteria and aerosol infections
112
M. tuberculosis Erdman strain (TMCC 107) was used for aerosol infections of mice for 113 drug evaluations and prepared as previously described (25, 26). Briefly, the bacteria were 114 originally grown as a pellicle to generate low passage seed lots (25). Working stocks were 115 generated by growing to mid-log phase in Proskauer-Beck medium containing 0.05% Tween 80
116
(Sigma-Aldrich, St. Louis, MO) in three passages, enumerated by serial dilution on 7H11 agar 117 plates, divided into 1.5 ml aliquots and stored at -80C until use.
118
C3HeB/FeJ mice and BALB/c mice were exposed to a low-dose aerosol infection with
119
M. tuberculosis in a Glas-Col inhalation exposure system, as previously described (26). The 
Statistical analysis
159
The viable CFU counts were converted to logarithms, which were then evaluated by a one- 
277
In order to ensure that the diminished CFZ activity in the lungs was not due to a specific 278 inherent characteristic of the C3HeB/FeJ mouse strain, we showed in a subsequent study using We found that CFZ was highly effective in both the lungs and spleens of GKO mice when 306 administered for nine days. This efficacy was similar to that observed in BALB/c mice. These To further examine the potential role of molecular oxygen in the attenuation of CFZ 342 activity, we evaluated CFZ activity in M. tuberculosis cultures at various oxygen concentrations.
343
For this purpose, we utilized the in vitro RAD bacterial culture model to generate hypoxic and 344 completely anaerobic bacterial cultures (28). In this assay, the active metabolism of the bacilli 345 drives the oxygen concentration in the headspace of sealed culture tubes over time to 346 undetectable levels (28). In these studies, CFZ activity decreased significantly when cultured 347 under hypoxic conditions, and the activity was further attenuated in the absence of oxygen.
348
These results were somewhat surprising, as other researchers have reported that CFZ had 349 significant anti-mycobacterial activity using different low oxygen in vitro culture systems (8, 41, 350 42). In our assay, the loss of oxygen was monitored using methylene blue as an indicator to 351 demonstrate that the cultures were hypoxic (30). In addition, we harvested, manipulated, and conditions. However, it should be noted that even when cultured under completely anaerobic 360 conditions using the RAD model, CFZ still retained ~1 log 10 of bactericidal activity (as seen in 361 Figure 5C ) suggesting that other mechanisms in addition to molecular oxygen may potentially 362 contribute to the observed killing. In that respect, we can speculate that other electron donors 
